Total Payments
$46,082
2023 Payments
$2,094
Companies
36
Transactions
755
Medicare Patients
1,535
Medicare Billing
$318,287
Payment Breakdown by Category
Other$27,169 (59.0%)
Food & Beverage$18,126 (39.3%)
Consulting$592.50 (1.3%)
Travel$91.08 (0.2%)
Gifts$73.14 (0.2%)
Education$31.37 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27,169 | 16 | 59.0% |
| Food and Beverage | $18,126 | 724 | 39.3% |
| Consulting Fee | $592.50 | 2 | 1.3% |
| Travel and Lodging | $91.08 | 3 | 0.2% |
| Gift | $73.14 | 5 | 0.2% |
| Education | $31.37 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $31,293 | 182 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $1,821 | 64 | $0 (2023) |
| Validus Pharmaceuticals LLC | $1,336 | 29 | $0 (2023) |
| Alkermes, Inc. | $1,193 | 29 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $1,110 | 19 | $0 (2023) |
| Lundbeck LLC | $1,094 | 55 | $0 (2023) |
| Allergan, Inc. | $1,010 | 37 | $0 (2020) |
| ITI, Inc. | $896.93 | 30 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $746.81 | 36 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $715.82 | 37 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $2,094 | 90 | Axsome Therapeutics, Inc. ($363.81) |
| 2022 | $1,936 | 79 | Alkermes, Inc. ($414.32) |
| 2021 | $2,756 | 85 | Validus Pharmaceuticals LLC ($867.89) |
| 2020 | $2,760 | 103 | Sunovion Pharmaceuticals Inc. ($1,284) |
| 2019 | $3,618 | 129 | Sunovion Pharmaceuticals Inc. ($989.43) |
| 2018 | $18,446 | 146 | Sunovion Pharmaceuticals Inc. ($15,641) |
| 2017 | $14,472 | 123 | Sunovion Pharmaceuticals Inc. ($13,007) |
All Payment Transactions
755 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Neurology | ||||||
| 12/20/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: INSOMNIA | ||||||
| 12/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: CNS | ||||||
| 12/01/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | Cash or cash equivalent | $121.83 | General |
| Category: Neurology | ||||||
| 11/28/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Central Nervous System | ||||||
| 11/27/2023 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $21.85 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: PSYCHIATRY | ||||||
| 11/09/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Central Nervous System | ||||||
| 11/07/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: INSOMNIA | ||||||
| 11/02/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: CNS | ||||||
| 10/26/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: Neurology | ||||||
| 10/23/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.41 | General |
| Category: PSYCHIATRY | ||||||
| 10/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 362 | 1,094 | $184,680 | $67,061 |
| 2022 | 3 | 402 | 1,382 | $224,555 | $95,064 |
| 2021 | 4 | 369 | 1,196 | $182,608 | $89,399 |
| 2020 | 5 | 402 | 992 | $157,265 | $66,764 |
Total Patients
1,535
Total Services
4,664
Medicare Billing
$318,287
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 177 | 558 | $103,230 | $38,727 | 37.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 174 | 522 | $78,300 | $27,339 | 34.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 11 | 14 | $3,150 | $995.96 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 187 | 691 | $121,045 | $51,144 | 42.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 184 | 660 | $92,350 | $37,777 | 40.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 31 | 31 | $11,160 | $6,143 | 55.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 171 | 644 | $106,133 | $51,464 | 48.5% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 164 | 509 | $63,625 | $31,042 | 48.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 23 | 23 | $8,050 | $4,562 | 56.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 20 | $4,800 | $2,331 | 48.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 178 | 562 | $92,730 | $36,301 | 39.1% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 144 | 328 | $41,000 | $19,832 | 48.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 45 | 59 | $13,485 | $5,653 | 41.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 18 | 18 | $6,300 | $3,124 | 49.6% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 17 | 25 | $3,750 | $1,854 | 49.4% |
About Dr. Bruce Rosen, MD
Dr. Bruce Rosen, MD is a Psychiatry healthcare provider based in Smithtown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649343245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Rosen, MD has received a total of $46,082 in payments from pharmaceutical and medical device companies, with $2,094 received in 2023. These payments were reported across 755 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($27,169).
As a Medicare-enrolled provider, Rosen has provided services to 1,535 Medicare beneficiaries, totaling 4,664 services with total Medicare billing of $318,287. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Smithtown, NY
- Active Since 11/15/2006
- Last Updated 04/16/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1649343245
Products in Payments
- LATUDA (Drug) $31,293
- REXULTI (Drug) $1,936
- VRAYLAR (Drug) $1,476
- Equetro (Drug) $1,336
- INGREZZA (Drug) $1,110
- CAPLYTA (Drug) $896.93
- TRINTELLIX (Drug) $812.94
- ABILIFY MAINTENA (Drug) $692.48
- ARISTADA (Drug) $650.59
- SPRAVATO (Drug) $486.92
- AUSTEDO (Drug) $478.03
- BELSOMRA (Drug) $461.64
- Sunosi (Drug) $363.81
- Trintellix (Drug) $308.85
- SUBLOCADE (Drug) $232.41
- NEUROSTAR TMS THERAPY (Device) $231.30
- VYVANSE (Drug) $231.27
- LYBALVI (Drug) $224.58
- NUEDEXTA (Drug) $220.55
- Austedo XR (Drug) $186.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Smithtown
Robert Castroll, Md, MD
Psychiatry — Payments: $20,986
Psychiatry $20,986
Shelley Epstein, Md, MD
Psychiatry — Payments: $13,002
Psychiatry $13,002
Suzanne Tuzel, Md, MD
Psychiatry — Payments: $9,906
Psychiatry $9,906
Dr. Maria Benetos, Do, DO
Psychiatry — Payments: $3,293
Psychiatry $3,293
Dr. Christopher Burke, M.d, M.D
Psychiatry — Payments: $1,541
Psychiatry $1,541
Dr. Devendra Amin, M.d, M.D
Psychiatry — Payments: $1,466
Psychiatry $1,466